跳至主要内容
临床试验/IRCT20081019001369N8
IRCT20081019001369N8招募中2 期

Evaluation of Preventive Effect of Intravenous Trans Sodium Crocetinate on Contrast-Induced Nephropathy in Patients Undergoing Coronary Angioplasty : A randomized placebo-controlled triple-blind clinical trail

Mashhad University of Medical Sciences0 个研究点目标入组 152 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
入组人数
152

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • Candidates for outpatient angioplasty

排除标准

  • The presence of ESRD requires dialysis before angiography
  • Presence of underlying diseases leading to acute renal failure regardless of contrast-induced acute renal failure
  • Existence of active tumor
  • History of exposure to intravenous contrast agents in the last 14 days for other reasons
  • Existence of heart failure or cardiogenic shock
  • Taking drugs interacting kidney function

研究者

相似试验